Buy or sell Insitro stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Insitro Stock

Insitro is revolutionizing pharmaceutical R&D by leveraging machine learning for drug discovery.

About Insitro Stock

Over the past decades, developing drugs has become increasingly more difficult and expensive, leaving many patients with significant unmet need. A constellation of technologies now allows us to construct, perturb, and observe biological model systems in the laboratory, allowing the generation of biomolecular data at unprecedented breadth and scale. At the same time, the tools of data science and machine learning are now solving problems previously thought to be decades away from solution. We aim to combine these technologies to develop a new approach to drug development that might help us cure more people, sooner, and at a much lower cost.

Funding History

May 2018$0

Management

Founder & CEO

Daphne Koller

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Insitro or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo